LBLisa L. Barnes

Lisa L. Barnes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lisa L. Barnes has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • David A. Bennett

    Rush Alzheimer's Disease Center,Rush University Medical Center,Chicago,Illinois

    5 shared publications
  • Robert S. Wilson

    Rush Alzheimer's Disease Center,Rush University Medical Center,Chicago,Illinois

    5 shared publications
  • Denis A. Evans

    Department of Neurological Sciences 4 Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois 6 Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois

    4 shared publications
  • Carlos F. Mendes de Leon

    Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois 6 Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois

    3 shared publications
  • D.A. Bennett

    Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, Illinois

    3 shared publications
  • Ana W. Capuano

    Rush Alzheimer's Disease Center 2 Department of Neurological Sciences

    2 shared publications

Latest Publications

  • Open Access

    MetaVoxel: Joint Diffusion Modeling of Imaging and Clinical Metadata

    by Yihao Liu, Chenyu Gao, Lianrui Zuo, Michael E. Kim, Brian D. Boyd, Lisa L. Barnes, Walter A. Kukull, Lori L. Beason-Held, Susan M. Resnick, Timothy J. Hohman, et al.

    Modern deep learning methods have achieved impressive results across tasks from disease classification, estimating continuous biomarkers, to generating realistic medical images. Most of these approaches are trained to model conditional distributions defined by a specific predictive direction with a specific set of input variables. We introduce MetaVoxel, a generative joint diffusion modeling framework that models the joint distribution over imaging data and clinical metadata by learning a single diffusion process spanning all variables. By capturing the joint distribution, MetaVoxel unifies tasks that traditionally require separate conditional models and supports flexible zero-shot inference using arbitrary subsets of inputs without task-specific retraining. Using more than 10,000 T1-weighted MRI scans paired with clinical metadata from nine datasets, we show that a single MetaVoxel model can perform image generation, age estimation, and sex prediction, achieving performance comparable to established task-specific baselines. Additional experiments highlight its capabilities for flexible inference. Together, these findings demonstrate that joint multimodal diffusion offers a promising direction for unifying medical AI models and enabling broader clinical applicability.

  • Open Access

    Interactive Effects of HLA and GM Alleles on the Development of Alzheimer Disease

    by Janardan P. Pandey, Paul J. Nietert, Ronald T. Kothera, Lisa L. Barnes, David A. Bennett

    Objective We investigated whether particular immunoglobulin GM (γ marker) alleles—individually or epistatically with a known human leukocyte antigen (HLA) risk allele—were associated with the development of Alzheimer disease (AD). Methods Using a prospective cohort study design, we genotyped DNA samples from 209 African American (AA) and 638 European American (EA) participants for IgG1 (GM 3 and GM 17), IgG2 (GM 23+ and GM 23−), and HLA-DRB1 rs9271192 (A/C) alleles by TaqMan and rhAMP genotyping assays. Results In EA subjects, none of the GM or HLA alleles—individually or epistatically—were associated with time to development of AD. In AA subjects, GM and HLA alleles individually were not associated with time to development of AD. However, there was a significant interaction: In the presence of GM 3 (i.e., GM 3/3 and GM 3/17 subjects), the presence of the HLA-C allele was associated with a 4-fold increase in the likelihood of developing AD compared with its absence (hazard ratio [HR] 4.17, 95% CI, 1.28–13.58). In the absence of GM 3 (GM 17/17 subjects), however, the presence of the HLA-C allele was not associated with time to development of AD (HR 1.10, 95% CI, 0.50–2.41). Conclusions These results show that particular GM and HLA alleles epistatically contribute to the development of AD.


  • Sex differences in mixed neuropathologies in community-dwelling older adults

    by Lisa L. Barnes, Melissa Lamar, Julie A. Schneider


  • Examination of the Factor Structure of a Global Cognitive Function Battery across Race and Time

    by Lisa L. Barnes, Futoshi Yumoto, Ana Capuano, Robert S. Wilson, David A. Bennett, Rochelle E. Tractenberg

    Older African Americans tend to perform more poorly on cognitive function tests than older Whites. One possible explanation for their poorer performance is that the tests used to assess cognition may not reflect the same construct in African Americans and Whites. Therefore, we tested measurement invariance, by race and over time, of a structured 18-test cognitive battery used in three epidemiologic cohort studies of diverse older adults. Multi-group confirmatory factor analyses were carried out with full-information maximum likelihood estimation in all models to capture as much information as was present in the observed data. Four different aspects of the data were fit to each model: comparative fit index (CFI), standardized root mean square residuals (SRMR), root mean square error of approximation (RMSEA), and model $$\chi ^{2} $$ . We found that the most constrained model fit the data well (CFI=0.950; SRMR=0.051; RMSEA=0.057 (90% confidence interval: 0.056, 0.059); the model $$\chi ^{2} $$ =4600.68 on 862 df), supporting the characterization of this model of cognitive test scores as invariant over time and racial group. These results support the conclusion that the cognitive test battery used in the three studies is invariant across race and time and can be used to assess cognition among African Americans and Whites in longitudinal studies. Furthermore, the lower performance of African Americans on these tests is not due to bias in the tests themselves but rather likely reflect differences in social and environmental experiences over the life course. (JINS, 2016, 22, 66–75)


  • Mixed pathology is more likely in black than white decedents with Alzheimer dementia

    by Lisa L. Barnes, Sue Leurgans, Neelum T. Aggarwal, Raj C. Shah, Zoe Arvanitakis, Bryan D. James, Aron S. Buchman, David A. Bennett, Julie A. Schneider

    Objective: To compare the burden of neuropathology in black and white participants with clinical Alzheimer disease (AD). Methods: Participants included 122 persons enrolled in the Rush Alzheimer9s Disease Clinical Core, a prospective cohort study of AD. Forty-one black decedents were matched two-to-one to 81 white decedents according to age at death, sex, years of education, and cognition proximate to death. We examined common brain pathologies related to dementia (AD, Lewy body, and macroscopic and microinfarct pathology) and arteriolar sclerosis and atherosclerosis. We calculated the frequency of each dementia pathology both alone and in combination (mixed pathologies). Racial differences in the odds of a single pathology vs mixed pathologies, and in the odds of vessel disease and its severity, were examined using logistic regression analyses. Results: AD pathology was confirmed in >93% of both black and white decedents with AD dementia. However, black decedents were less likely to have Alzheimer pathology as a single dementia pathology than white decedents (19.5% vs 42.0%), and were more likely to have AD mixed with an additional pathology (70.7% vs 50.6%), particularly Alzheimer pathology and Lewy bodies, and Alzheimer pathology, Lewy bodies, and infarcts. Black decedents also had more severe arteriolar sclerosis and atherosclerosis. Conclusion: Black decedents with AD dementia are more likely to have mixed brain pathologies compared with age-, sex-, education-, and cognition-matched white decedents with AD dementia.


  • Open Access

    Reply to Itzhaki

    by Lisa L. Barnes, Ana W. Capuano, Allison E. Aiello, Arlener D. Turner, Robert H. Yolken, E. Fuller Torrey, David A. Bennett

    To the Editor—We thank Drs Itzhaki and Klapper for their interest in and comments regarding our study [1], which examined the relationship between cytomegalovirus (CMV) infection and risk of Alzheimer's disease (AD). We found that CMV seropositivity was associated with a 2-fold increase in risk of AD and a faster rate of cognitive decline. The results were robust to a number of covariates, including herpes simplex virus type 1 (HSV-1). In addition, our findings support earlier cohort studies that have examined the association between CMV and cognitive function [2, 3]. Together, these studies suggest a potential role for CMV as a factor that may influence cognition and risk of AD in older ages.


  • Open Access

    Cytomegalovirus Infection and Risk of Alzheimer Disease in Older Black and White Individuals

    by Lisa L. Barnes, Ana W. Capuano, Alison E. Aiello, Arlener D. Turner, Robert H. Yolken, E. Fuller Torrey, David A. Bennett

    Human cytomegalovirus (CMV) is prevalent in older adults and has been implicated in many chronic diseases of aging. This study investigated the relation between CMV and the risk of Alzheimer disease (AD). Data come from 3 cohort studies that included 849 participants (mean age [±SD], 78.6 ± 7.2 years; mean education duration [±SD], 15.4 ± 3.3 years; 25% black). A solid-phase enzyme-linked immunosorbent assay was used for detecting type-specific immunoglobulin G antibody responses to CMV and herpes simplex virus type 1 (HSV-1) measured in archived serum samples. Of 849 participants, 73.4% had serologic evidence of exposure to CMV (89.0% black and 68.2% white; P < .001). During an average of 5.0 years of follow-up, 93 persons developed AD. CMV seropositivity was associated with an increased risk of AD (relative risk, 2.15; 95% confidence interval, 1.42–3.27) and a faster rate of decline in global cognition (estimate [±standard error], −0.02 ± 0.01; P = .03) in models that controlled for age, sex, education duration, race, vascular risk factors, vascular diseases, and apolipoprotein ε4 level. Results were similar in black and white individuals for both incident AD and change in cognitive function and were independent of HSV-1 status. These results suggest that CMV infection is associated with an increased risk of AD and a faster rate of cognitive decline in older diverse populations.


  • Apolipoprotein E and Change in Episodic Memory in Blacks and Whites

    by L.L. Barnes, Z. Arvanitakis, L. Yu, J. Kelly, P.L. De Jager, D.A. Bennett

    Background: Apolipoprotein E (APOE) ε4 is related to faster decline in episodic memory in Whites, but the relation is unknown in Blacks. The purpose of this study was to determine whether ε4 has a selective effect on decline in episodic memory in Blacks. Methods: Data are from two cohort studies with similar design. The sample consisted of 1,211 participants [28.4% Blacks, mean age = 78.6 years (SD = 7.4), education = 14.7 years (SD = 3.1)] without dementia at baseline, who underwent annual clinical evaluations for up to 6 years. Summary measures of 5 cognitive abilities were derived from 18 neuropsychological tests. Results: In mixed models that controlled for age, sex, education, and race, possession of ε4 (present in 32.9% of Blacks and 21.0% of Whites, p < 0.001) was related to faster decline in episodic memory and 4 other cognitive abilities (all p values Conclusions: The results suggest that APOE ε4 is related to a faster rate of decline in episodic memory in Blacks similar to Whites. In addition, there were racial differences in the effect of ε4 in other cognitive abilities such that the ε4 allele was related to faster decline in semantic memory and working memory for Whites but not for Blacks.


  • Perceived Discrimination and Cognition in Older African Americans

    by L.L. Barnes, T.T. Lewis, C.T. Begeny, L. Yu, D.A. Bennett, R.S. Wilson

    Existing evidence suggests that psychosocial stress is associated with cognitive impairment in older adults. Perceived discrimination is a persistent stressor in African Americans that has been associated with several adverse mental and physical health outcomes. To our knowledge, the association of discrimination with cognition in older African Americans has not been examined. In a cohort of 407 older African Americans without dementia (mean age = 72.9;SD= 6.4), we found that a higher level of perceived discrimination was related to poorer cognitive test performance, particularly episodic memory (estimate = −0.03;SE= .013;p< .05) and perceptual speed tests (estimate = −0.04;SE= .015;p< .05). The associations were unchanged after adjusting for demographics and vascular risk factors, but were attenuated after adjustment for depressive symptoms (Episodic memory estimate = −0.02;SE= 0.01; Perceptual speed estimate = −0.03;SE= 0.02; bothp's = .06). The association between discrimination and several cognitive domains was modified by level of neuroticism. The results suggest that perceived discrimination may be associated with poorer cognitive function, but does not appear to be independent of depressive symptoms. (JINS, 2012,18, 1–10)


  • Open Access

    Racial Differences in the Association of Education With Physical and Cognitive Function in Older Blacks and Whites

    by Lisa L. Barnes, Robert S. Wilson, Liesi E. Hebert, Paul A. Scherr, Denis A. Evans, Carlos F. Mendes de Leon

    Few studies have explicitly tested whether the health disadvantage among older Blacks is consistent across the entire range of education. We examined racial differences in the cross-sectional association of education with physical and cognitive function performance in older adults. Participants included over 9,500 Blacks and Whites, aged ≥65 years, from the Chicago Health and Aging Project {64% Black, 60% women, mean age = 73.0 (standard deviation [SD] = 6.9), mean education = 12.2 (SD = 3.5)}. Physical function was assessed using 3 physical performance tests, and cognitive function was assessed with 4 performance-based tests; composite measures were created and used in analyses. In multiple regression models that controlled for age, age-squared, sex, and race, and their interactions, Whites and those with higher education (>12 years) performed significantly better on both functional health measures. The association of education with each indicator of functional health was similar in older Blacks and Whites with low levels (≤12 years) of education. However, at higher levels of education, there was a significantly more positive association between years of education and these functional health outcomes among Blacks than Whites. Results from this biracial population-based sample in the Midwest suggest that Blacks may enjoy greater returns in functional health for additional education beyond high school.